Vaccination
Egypt has commenced its nationwide vaccination campaign against the novel coronavirus (COVID-19) with the arrival of the first shipment of the AstraZeneca/Oxford University vaccine. The vaccine will initially be administered to frontline health workers, the elderly, and those with chronic health issues. The Egyptian Drug Authority (EDA) has approved
Pharmaceutical industry
European Union regulators are gearing up to announce potential restrictions on the export of Covid-19 vaccines, following a high-stakes dispute between the bloc and pharmaceutical companies over reduced supplies. As the European Union continues to grapple with delays and controversies surrounding the rollout of the AstraZeneca vaccine, EU officials are
Vaccines
The European Union regulators have greenlit the AstraZeneca COVID-19 vaccine for use in adults, addressing concerns over the pace of vaccination in the EU. This move comes after criticism of the European Medicines Agency for not acting quickly enough to vaccinate its population. However, concerns had been raised about the
Vaccines
Australia's vaccine rollout plan has been clouded by the European Union's decision to impose export controls on COVID-19 vaccines, including those produced in Europe by Pfizer and AstraZeneca. The Morrison government's vaccination plan relies heavily on imports, including 10 million doses of the Pfizer
Pharmaceutical industry
Thousands of farmers took to the streets in India's capital, New Delhi, on Republic Day, as part of nationwide protests against agricultural laws that farmers claim put their livelihoods at risk. The demonstrations, which saw farmers storming the historic Red Fort, are seen as the biggest challenge to
Pfizer Inc.
The World Health Organization (WHO) has announced the signing of an advance purchase agreement with Pfizer-BioNTech to secure up to 40 million doses of the COVID-19 vaccine under the UN-led COVAX equitable vaccine supply programme. Additionally, 150 million doses of the AstraZeneca/Oxford vaccine are expected to be available for
Pfizer Inc.
The global cellular immunotherapy market experienced a decline in 2020 due to the COVID-19 pandemic, with a CAGR of -5.90% and a revenue of $2.74 billion. However, the market is expected to recover and reach $5.05 billion in 2023, with a CAGR of 22.53%. The market
Pharmaceutical industry
The US FDA has approved Daiichi's breast cancer drug for broader use in the US, while President Biden maintains Dr. Francis Collins as the National Institutes of Health director. The administration is also renaming "Operation Warp Speed" due to perceived failures under the Trump administration. Meanwhile,
Pharmaceutical industry
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, has stated that two more COVID-19 vaccines, developed by AstraZeneca and Johnson & Johnson, could be approved by the US Food and Drug Administration (FDA) within weeks. This news comes as President-elect Joe Biden aims to administer
Vaccines
The European Union has begun the approval process for its third vaccine against the coronavirus, despite the World Health Organization warning that achieving herd immunity this year is unlikely, even with mass inoculation schemes. The 27-member EU has promised an accelerated timeline after confirming that drug company AstraZeneca had applied
COVID-19 vaccines
Australia's chief medical officer, Professor Paul Kelly, has defended the country's decision to secure 54m doses of the Covid-19 vaccine made by Oxford University and pharmaceutical company AstraZeneca, despite concerns that it may not be effective enough to achieve herd immunity. The vaccine has been criticized
Vaccines
Johnson & Johnson's one-dose COVID-19 vaccine regimen is poised to play a crucial role in expanding vaccine access in the US and beyond, despite the faltering immunization push. The pharmaceutical giant is in the final stages of data analysis for its phase 3 trial, with CEO Alex Gorsky
